Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: BiBBInstruments ready for active near-term future

In its report for the first half of the year, BiBBInstruments highlights a completed pilot study in muscle-invasive bladder cancer, a successful presentation at the DDW congress, and a high level of regulatory activity. Another eventful period awaits, bringing the company closer to its goal of revolutionising cancer diagnostics with EndoDrill.Read the article at biostock.se: https://www.biostock.se/en/2022/08/bibbinstruments-star-infor-en-handelserik-fas/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Veidekke: Mandatory notification of trade – Exercise of employee share options in Veidekke ASA

With reference to the stock exchange announcement dated August 29, 2022, primary insider notifications pursuant to the market abuse regulation article 19 are attached. For further information, please contact: Jørgen Wiese Porsmyr, CFO, +47 907 59 058, jorgen-wiese.porsmyr@veidekke.no This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

P CAPITAL PARTNERS ALPHA AB (PUBL) INTERIM REPORT 2022

PRESS RELEASE Stockholm, 31 August 2022 P Capital Partners Alpha AB (publ) has today published its Interim Report for 2022. The report can be downloaded from the company website www.pcapital.se. P Capital is an active credit investor and loan provider to Northern and Western European companies in need of capital for expansion, acquisition financing, restructurings and refinancing. P Capital also conducts investments in publicly traded corporate credits. The P Capital Partners Alpha profit participation loan debentures are issued by P Capital Partners Alpha AB (publ) and are listed

P CAPITAL PARTNERS III AB (PUBL) INTERIM REPORT 2022

PRESS RELEASE Stockholm, 31 August 2022 P Capital Partners III AB (publ) has today published its Interim Report for 2022. The report can be downloaded from the company website www.pcapital.se. P Capital is an active credit investor and loan provider to Northern and Western European companies in need of capital for expansion, acquisition financing, restructurings and refinancing. P Capital also conducts investments in publicly traded corporate credits. The P Capital Partners III series A1 and series B profit participation loan debentures are issued by P Capital Partners III AB (publ)

Scandinavian ChemoTech's subsidiary Vetiqure AB receives a first order from Hasvet Medikal AS

Scandinavian ChemoTech's subsidiary Vetiqure AB has today received a first order from the Turkish distributor Hasvet Medikal AS ”Hasvet”. The order value amounts to EUR 11,200.The order follows the exclusive distributor agreement between Vetiqure and Hasvet that was previously communicated. Through the order, Hasvet can begin marketing in Turkey and demonstrate the benefits of vetIQure´sTM Tumour Specific Electroporation (TSE) technology to the many clinics the company covers. According to Hasvet, Hasvet's market share today amounts to 80% of the Turkish veterinary medicine market, which

P CAPITAL PARTNERS IV AB (PUBL) INTERIM REPORT 2022

PRESS RELEASE Stockholm, 31 August 2022 P Capital Partners IV AB (publ) has today published its Interim Report for 2022. The report can be downloaded from the company website www.pcapital.se. P Capital is an active credit investor and loan provider to Northern and Western European companies in need of capital for expansion, acquisition financing, restructurings and refinancing. P Capital also conducts investments in publicly traded corporate credits. The P Capital Partners IV series A1 profit participation loan debentures are issued by P Capital Partners IV AB (publ) and listed on

P CAPITAL PARTNERS IV B AB (PUBL) INTERIM REPORT 2022

PRESS RELEASE Stockholm, 31 August 2022 P Capital Partners IV B AB (publ) has today published its Interim Report for 2022. The report can be downloaded from the company website www.pcapital.se. P Capital is an active credit investor and loan provider to Northern and Western European companies in need of capital for expansion, acquisition financing, restructurings and refinancing. P Capital also conducts investments in publicly traded corporate credits. The P Capital Partners IV B series A1 participation loan debentures and series B profit participation loan debentures are issued by

BioStock: Phase II focus and further potential in Annexin´s Q2

In this year’s Q2 report, Annexin Pharmaceuticals emphasises intensive work with the phase II study within RVO, a great deal of interest for ANXV being seen from the industry, and that opportunities are also seen in the cancer area onwards. In the near future, new leaps are expected to be taken within both the phase II study and an imaging study for ANXV. Overall, CEO Anders Haegerstrand sees an exciting autumn ahead for the company.Read the full article about Annexin Pharmaceuticals at biostock.se: https://www.biostock.se/en/2022/08/phase-ii-focus-and-further-potential-in-annexins-q2/

Enersense International Plc: Flagging notification under chapter 9, section 10 of the Securities Markets Act

Enersense International PlcStock exchange release, 31 August 2022 at 11.15 a.m.Enersense International Plc has received a notification under chapter 9, section 5 of the Securities Markets Act from Kyösti Kakkonen. According to the notification, the shareholding of Joensuun Kauppa ja Kone Oy, a company controlled by Kyösti Kakkonen, in Enersense International Plc has fallen to 4.81 % of all shares in Enersense International Plc on 31 August 2022. According to the notification, the company holds a total of 784,510 shares in Enersense International Plc, which corresponds to 4.81 % of all

Orexo to participate in Pareto Securities´ 13th Annual Healthcare Conference

Uppsala, Sweden – August 31, 2022 – Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), which develops improved pharmaceuticals and evidence-based digital therapeutics primarily targeting the US market where its commercial organization is located, today announces the company will participate in Pareto Securities´ 13th Annual Healthcare Conference, that takes place on September 7-8, 2022, at Sergel Hub, Sveavägen 10 A, Stockholm, Sweden.   On September 7th at 2.30 pm CET, Nikolaj Sørensen, President and CEO at Orexo, will give a company presentation. Nikolaj Sørensen and the company’s new CFO

Valo Motion officially launches ValoArena live at IAAPA Expo trade show in London, and welcomes attendees and media to come try it out

Finnish mixed reality (MR) gaming company introduces groundbreaking headset-free Mixed Reality unit, ValoArena, to attraction industry professionals.HELSINKI, Finland (August 31, 2022) Today, Valo Motion  announces that its new immersive Mixed Reality indoor-arena, ValoArena , will have its official live launch at the IAAPA Expo trade show  from September 13–15 in London. Designed for activity parks and other indoor spaces, the freeform game requires no wearables for gameplay, allowing

BioStock: Cyxone looks forward to study start

Biopharmaceutical company Cyxone is fully focused on the upcoming phase IIb study with the candidate Rabeximod in rheumatoid arthritis. In the company's recently published interim report, acting CEO Carl-Magnus Högerkorp describes the preparatory work and updates on events in the company's pipeline. BioStock reached out to Högerkorp to find out more about the study and coming activities.Read the interview with Cyxone's acting CEO Carl-Magnus Högerkorp at biostock.se: https://www.biostock.se/en/2022/08/cyxone-looks-forward-to-study-start/ This is a press release from BioStock -

Wärtsilä to supply propulsion package for world’s largest aluminium catamaran

Wärtsilä Corporation, Press release, 31 August 2022 at 10.30 AM EESTThe technology group Wärtsilä will supply the engines, waterjets, and fuel storage and supply system for a new high speed catamaran ferry. The vessel is being built at the Incat yard in Tasmania, Australia on behalf of Argentinian ferry operator, Buquebus. Having an overall length of 130 metres, a width of 32 metres and the capacity to carry 2,100 passengers and 226 cars, it will be the largest aluminium catamaran ever built by Incat. The order with Wärtsilä was placed in July 2022. The vessel will operate between

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 170 - 31 AUGUST 2022   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Correction: Wyld Networks’ Interim Report Q2 2022: Scaling up to full commercial launch

Correction: In the original press release for the interim report January - June 2022 (published today at 08:45) the MAR label was omitted. It is now added.Wyld continue to sign strategic launch partners, build on the purchase order book and successfully complete end-to-end testing of the satellite IoT network.CEO Alastair Williamson: “In Q2 Wyld’s development team finished the end-to-end testing of the satellite network. We have become the world’s first company to successfully connect a terminal integrated with Semtech’s LR-FHSS (long-range frequency hopping spread spectrum) chip

BioStock: Pila Pharma broadens XEN-D0501 with new indication

During spring, Malmö-based Pila Pharma announced that they had applied for orphan drug designation for the drug candidate XEN-D0501 for the treatment of erythromelalgia. In mid-July, the company announced that the FDA had given the application the green light and with previous clinical findings as a base, the project can go straight into clinical phase II/III studies. BioStock contacted Pila Pharma’s CEO Dorte X. Gram to find out more about what the summer’s big news means for the company.Read the full article at biostock.se:https://www.biostock.se/en/2022/08/pila-pharma-broadens-xen-

The Findynet Cooperative receives a government grant to develop a trusted way to share information in electronic interactions

The Finnish Ministry of Finance has granted the Findynet Cooperative a three-million-euro government grant to build a pilot environment for a self-sovereign identity network. The aim of this public-private cooperation is to strengthen Finland's leading position in digitalization and support the emergence of investments in new digital services.The Findynet Cooperative aims to develop a network that ensures that digital wallets developed by different service providers are interoperable, and work seamlessly for both organizations and individuals. Digital wallets enable individuals and

SLP welcomes OAS Company to its new premises in Borås

SLP has signed a five-year lease agreement with OAS Company AB for approximately 4,000 sqm. in the logistics property Vindspelet 1 in Borås, Sweden. The property is located in the area of Viared and has close access to highway 40 in the direction of Gothenburg with an excellent signposted location. The current tenant will move out on 30 September and OAS Company will move in on 1 October 2022. Total area of the property is 11,045 sqm with an annual rent of approximately SEK 6.1 million.“Borås is a classic textile and trading centre and has an excellent logistics location. SLP has several

Movinn H1 2022 - Interim Report: 32% topline growth, profitable growth and improved fundamental metrics.

We are executing on our international launches and the existing Danish business are growing and displaying profitable growth. Added investments across all investment items are creating more depreciations then forecasted.Company Announcement nr. 18 - 202231 August 2022 09.00 CET. This company announcement contains inside information.  Copenhagen, Denmark - The Interim Report covers results from the first half (H1) of the year (1 January - 30 June 2022), as approved by Executive Management and the Board of Directors.  In H1 Movinn has realized revenue of 34 mDKK - up from 25.85 mDKK

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

ABS Signs Polish Offshore Wind Sector Deal

ABS joins government-industry collaboration to reach 11GW by 2040(GDAŃSK) American Bureau of Shipping Poland Sp. z.o.o. is supporting the development of Poland’s offshore wind market by signing the Polish Offshore Wind Sector Deal, an initiative that includes signatories such as TotalEnergies, Orsted, Equinor and Shell. Investors, developers and supply chain service companies joined the Polish government to develop a robust offshore wind industry. The initiative aims to generate 5.9 GW of electricity by 2030 and 11 GW by 2040, with the local economy and job creation at its heart. “ABS

Global esports platform Challengermode launches first of its kind mobile app to connect billions of gamers worldwide

Challengermode has launched its first official mobile app to offer a seamless competitive experience to gamers everywhere. The app links together game developers with competitive gamers across countless new and over 80 games using Challengermode’s esports tech and API.Stockholm, 31st August, 2022: Global esports platform Challengermode has today announced the launch of its first-of-its-kind mobile app for the esports space. The app will connect billions of gamers worldwide across PC, console and mobile with the grassroots esports scene through over 80 titles on the platform, and give

Aker Solutions Steps up Transparency around Reductions in Greenhouse Gas Emissions and Commits to Science Based Targets Initiative

August 31, 2022 – Aker Solutions announces today an acceptance of its ambitious climate commitment by the Science Based Targets initiative. In line with the science-based criteria, Aker Solutions is committed to halve greenhouse gas emissions from its own operations by 2030 and achieve net-zero by 2050.Science-based targets are emissions reduction targets in line with what the latest climate science deems necessary to meet the goals of the Paris Agreement. By developing targets using climate science and the Science Based Target initiative’s (SBTi) methodologies, Aker Solutions will promote

There are no items matching the current filter
There are no more items matching the current filter
Back to top